Pages that link to "Q24657630"
Jump to navigation
Jump to search
The following pages link to Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy (Q24657630):
Displaying 50 items.
- NT5E mutations and arterial calcifications (Q24607121) (← links)
- New perspectives on rare connective tissue calcifying diseases (Q26765164) (← links)
- From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders (Q26798431) (← links)
- Regulatory circuits controlling vascular cell calcification (Q26825788) (← links)
- Research Progress in Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders (Q26827073) (← links)
- Ectopic mineralization disorders of the extracellular matrix of connective tissue: molecular genetics and pathomechanisms of aberrant calcification (Q26865249) (← links)
- ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy (Q27343503) (← links)
- Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling (Q27673871) (← links)
- Effects of Different Variants in the ENPP1 Gene on the Functional Properties of Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Q28115649) (← links)
- Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations (Q28286551) (← links)
- Spontaneous asj-2J mutant mouse as a model for generalized arterial calcification of infancy: a large deletion/insertion mutation in the Enpp1 gene (Q28542530) (← links)
- Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel (Q33352008) (← links)
- Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets (Q33645895) (← links)
- Zebrafish enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE) (Q33814239) (← links)
- Elevated dietary magnesium during pregnancy and postnatal life prevents ectopic mineralization in Enpp1asj mice, a model for generalized arterial calcification of infancy (Q33888715) (← links)
- The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification (Q34821047) (← links)
- Npp1 promotes atherosclerosis in ApoE knockout mice (Q35161110) (← links)
- Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification (Q35525230) (← links)
- Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6 (Q35671719) (← links)
- Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene (Q35911423) (← links)
- Molecular diagnosis of generalized arterial calcification of infancy (GACI) (Q35966637) (← links)
- Mechanisms and clinical consequences of vascular calcification (Q36142207) (← links)
- The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene (Q36189282) (← links)
- Dual Effects of Bisphosphonates on Ectopic Skin and Vascular Soft Tissue Mineralization versus Bone Microarchitecture in a Mouse Model of Generalized Arterial Calcification of Infancy (Q36514754) (← links)
- Idiopathic Arterial Calcification of Infancy: Case Report (Q36912195) (← links)
- Expression of NPP1 is regulated during atheromatous plaque calcification (Q37294492) (← links)
- ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release (Q37395209) (← links)
- Mutations in the ABCC6 gene as a cause of generalized arterial calcification of infancy: genotypic overlap with pseudoxanthoma elasticum (Q37623356) (← links)
- Bisphosphonates use in children (Q38039262) (← links)
- ATP and arterial calcification (Q38080569) (← links)
- Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment (Q38740282) (← links)
- Where do we stand on vascular calcification? (Q38853714) (← links)
- Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications. (Q39071314) (← links)
- Insights into Pathomechanisms and Treatment Development in Heritable Ectopic Mineralization Disorders: Summary of the PXE International Biennial Research Symposium-2016. (Q39199332) (← links)
- Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts (Q39353783) (← links)
- Arterial calcification is driven by RAGE in Enpp1-/- mice (Q41202872) (← links)
- Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy (Q41277036) (← links)
- Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions (Q41354101) (← links)
- Generalized Arterial Calcification of Infancy: Fatal Clinical Course Associated with a Novel Mutation in ENPP1. (Q41773869) (← links)
- Idiopathic infantile arterial calcification: a possible cause of refractory cardiopulmonary failure in infancy. (Q41977470) (← links)
- Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin (Q41986289) (← links)
- Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy (Q42113848) (← links)
- Unusual cause of myocardial ischemia in an infant (Q46176577) (← links)
- Hypercementosis Associated with ENPP1 Mutations and GACI. (Q46240332) (← links)
- Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy (Q48379638) (← links)
- Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges (Q51192993) (← links)
- Heart transplant and 2-year follow up in a child with generalized arterial calcification of infancy. (Q53042515) (← links)
- Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. (Q53201640) (← links)
- ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. (Q53516359) (← links)
- Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification. (Q54858183) (← links)